Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Immune Cells in Cancer Therapy and Drug DeliveryInterleukin 12: still a promising candidate for tumor immunotherapy?Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemiaCD200R/Foxp3-mediated signalling regulates microglial activation.Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.Immunotherapy in acute myeloid leukemia.Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.Lung CD200 Receptor Activation Abrogates Airway Hyperresponsiveness in Experimental Asthma.Expression profiling of cancer-related galectins in acute myeloid leukemia.Interplay between human microglia and neural stem/progenitor cells in an allogeneic co-culture model.Ibrutinib treatment improves T cell number and function in CLL patients.Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200.Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus.Sodium valproate modulates immune response by alternative activation of monocyte-derived macrophages in systemic lupus erythematosus.Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.
P2860
Q26746104-A85CEB95-D8DB-4167-9A52-54F2981B82A6Q26747061-2731FF9E-25C3-4108-9878-E97B5D4D6096Q26861559-E5DBC10D-A3E9-42CF-B22A-E849B6BE6D42Q36557537-C7048C7B-E4F7-409D-A274-A4671DDA6ECCQ36771874-186B44C0-2B76-412C-94A4-E99F1C3BE2B7Q37330271-C1B6BCF8-DB6C-498A-8BC1-3ED665479DF5Q38485334-363F7225-2BCA-4D97-AEC1-FA6D771BD3A1Q38533606-6FF397AA-40D6-4850-9599-0563F35DF465Q38952569-E8CC574F-A499-4B67-9869-C0D25D8060D2Q41609027-B3DA21F4-7899-499C-A601-E3A2875888E9Q41753912-93237BDE-A466-44FA-850C-83BFF600BCC7Q41899624-5CEEC5B8-7CF7-423F-BE28-B9529D42E47EQ42909982-9F880975-A97E-454D-9340-06CEBF6AD56DQ46971015-95C3FE29-80DB-4446-81E4-1851D3CCF189Q47734736-85E685EB-9439-4438-BD9C-5FCA6BD7EACFQ49352534-67CF794D-768D-4953-8D6D-8664501BA9C5Q54213024-147C5888-C9C0-4D49-9EBA-60545E93E25DQ55354182-D4E97B61-E31A-4547-9481-D188CD0FC54C
P2860
Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Upregulation of CD200 is assoc ...... ion in acute myeloid leukemia.
@en
Upregulation of CD200 is assoc ...... ion in acute myeloid leukemia.
@nl
type
label
Upregulation of CD200 is assoc ...... ion in acute myeloid leukemia.
@en
Upregulation of CD200 is assoc ...... ion in acute myeloid leukemia.
@nl
prefLabel
Upregulation of CD200 is assoc ...... ion in acute myeloid leukemia.
@en
Upregulation of CD200 is assoc ...... ion in acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Upregulation of CD200 is assoc ...... ion in acute myeloid leukemia.
@en
P2093
Amir Hossein Emami
Farimah Masoumi
Jamshid Hadjati
Kamran Alimoghaddam
Mahroo Mirahmadian
Maryam Nourizadeh
Mina Tabrizi
P2860
P2888
P304
P356
10.1007/S13277-012-0578-X
P577
2012-11-18T00:00:00Z